ConductScience.org, home

Paper714108

Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.

Kiang DT and 4 others. N Engl J Med, 1978. Cited by 232 papers, by iCite.

Cite this record

ConductScience Library. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. Papers, record 714108. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/714108

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
232
iCite
Relative citation ratio, by iCite
8.47
iCite
Revised in PubMed
2006-11-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kiang DTD T
2Frenning DHD H
3Goldman AIA I
4Ascensao VFV F
5Kennedy BJB J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Adult
Aged
Antineoplastic Agents
Drug Therapy, Combination
Female
Humans
Menopause
Middle Aged
Neoplasm Metastasis
Prognosis
Retrospective Studies
Time Factors

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 232 citations.

PMIDTitleJournalYearIn PapersSource
42394902Self-assembled verteporfin nanoparticles decrease drug efflux by P-glycoprotein without light activation in drug-resistant cancer cells.Bioeng Transl Med2026https://conductscience.org/library/papers/42394902PubMed
40176396Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World Data.Thorac Cancer2025https://conductscience.org/library/papers/40176396PubMed
39077471Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.Front Oncol2024https://conductscience.org/library/papers/39077471PubMed
25368523The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case-control study.Onco Targets Ther2014https://conductscience.org/library/papers/25368523PubMed
23562473IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors.Cancer Lett2013https://conductscience.org/library/papers/23562473PubMed
21292829The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.Mol Endocrinol2011https://conductscience.org/library/papers/21292829PubMed
20164691Triple-negative breast cancer: role of specific chemotherapy agents.Cancer J2010https://conductscience.org/library/papers/20164691PubMed
19949674Impact of grade, hormone receptor, and HER-2 status in women with breast cancer on response to specific chemotherapeutic agents by in vitro adenosine triphosphate-based chemotherapy response assay.J Korean Med Sci2009https://conductscience.org/library/papers/19949674PubMed
19845944
Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.
BMC Cancer2009https://conductscience.org/library/papers/19845944PubMed
19591668The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.BMC Cancer2009https://conductscience.org/library/papers/19591668PubMed
15611798Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.Br J Cancer2005https://conductscience.org/library/papers/15611798PubMed
11173657Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.Pathol Oncol Res2000https://conductscience.org/library/papers/11173657PubMed
8281616Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.Cancer Metastasis Rev1993https://conductscience.org/library/papers/8281616PubMed
8012036Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.Breast Cancer Res Treat1994https://conductscience.org/library/papers/8012036PubMed
7459204Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients.Br J Cancer1980https://conductscience.org/library/papers/7459204PubMed
7400208The influence of estradiol and adriamycin on the RNA biosynthesis in breast cancer.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/7400208PubMed
7363400Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/7363400PubMed
7362774Clinical applications of receptor measurements in breast cancer.Br J Cancer1980https://conductscience.org/library/papers/7362774PubMed
7362189Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy.Ann R Coll Surg Engl1980https://conductscience.org/library/papers/7362189PubMed
7348580Effect of chemotherapy on survival in metastatic breast cancer.Breast Cancer Res Treat1981https://conductscience.org/library/papers/7348580PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/714108

GET https://conductscience.org/api/papers/v1/714108/cited_by?page=2